Anabolic–androgenic steroid use among Brazilian women: an exploratory investigation

References

• Abrahin, O. S. C., de Sousa, E. C., & Santos, A. M. (2014). Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review. Substance Use & Misuse, 49(9), 1156–1162.
   PubMed Web of Science ®Google Scholar
• Abrahin, O. S. C., Souza, N. S. F., Sousa, E. C. de, Moreira, J. K. R., & Nascimento, V. C. (2013). Prevalence of the use of anabolic androgenic steroids by physical education students and teachers who work in health clubs. Revista Brasileira de Medicina do Esporte, 19(1), 27–30.
   Web of Science ®Google Scholar
• Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., Choong, K., Lakshman, K. M., Mazer, N. A., Miciek, R., Krasnoff, J., Elmi, A., Knapp, P. E., Brooks, B., Appleman, E., Aggarwal, S., Bhasin, G., Hede-Brierley, L., Bhatia, A., Collins, L., LeBrasseur, N., Fiore, L. D., & Bhasin, S. (2010). Adverse events associated with testosterone administration. The New England Journal of Medicine, 363(2), 109–122.
   PubMed Web of Science ®Google Scholar
• Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001). Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology and Metabolism, 86(11), 5108–5117.
   PubMed Web of Science ®Google Scholar
• Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. The New England Journal of Medicine, 335(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Da Justa Neves, D. B., Marcheti, R. G. A., & Caldas, E. D. (2013). Incidence of anabolic steroid counterfeiting in Brazil. Forensic Science International, 228(1–3), e81–e83.
   PubMed Web of Science ®Google Scholar
• Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G. D., Hirschberg, A. L., Rodenberg, C., Pack, S., Koch, H., Moufarege, A., & Studd, J. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. The New England Journal of Medicine, 359(19), 2005–2017.
   PubMed Web of Science ®Google Scholar
• Dodge, T., & Hoagland, M.F. (2011). The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug and Alcohol Dependence, 114(2–3), 100–109.
   PubMed Web of Science ®Google Scholar
• Elliot, D. L., Cheong, J., Moe, E. L., & Goldberg, L. (2007). Cross-sectional study of female students reporting anabolic steroid use. Archives of Pediatrics & Adolescent Medicine 161(6), 572–577.
   PubMedGoogle Scholar
• Emmelot-Vonk, M. H., Verhaar H. J. J., & Nakhai Pour, H. R. (2008). Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. The Journal of the American Medical Association, 299(1), 29–52.
   Web of Science ®Google Scholar
• Evans, N. A. (1997). Gym and tonic: a profile of 100 male steroid users. British Journal of Sports Medicine, 31(1), 54–58.
   PubMed Web of Science ®Google Scholar
• Evans, N. A. (2004). Current concepts in anabolic-androgenic steroids. American Journal of Sports Medicine 32(2), 534–542.
   PubMed Web of Science ®Google Scholar
• Gruber, A. J., & Pope, H. G. (2000). Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychotherapy and Psychosomatics, 69(1), 19–26.
   PubMed Web of Science ®Google Scholar
• Hargreaves, D. A., & Tiggemann, M. (2009). Muscular ideal media images and men’s body image: Social comparison processing and individual vulnerability. Psychology of Men & Masculinity, 10, 109–119.
   Web of Science ®Google Scholar
• Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513–554.
   PubMed Web of Science ®Google Scholar
• Ip, E. J., Barnett, M. J., Tenerowicz, M. J., Kim, J. A, Wei, H., & Perry, P. J. (2010). Women and anabolic steroids: an analysis of a dozen users. Clinical Journal of Sport Medicine, 20(6), 475–481.
   PubMed Web of Science ®Google Scholar
• Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, 31(8), 757–766.
   PubMed Web of Science ®Google Scholar
• Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: a survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651.
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men. Archives of General Psychiatry 57(2), 133–140.
   PubMed Web of Science ®Google Scholar
• Rachoń, D., Pokrywka, L., & Suchecka-Rachoń, K. (2006). Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Sozial- und Präventivmedizin, 51(6), 392–398.
   PubMedGoogle Scholar
• Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398.
   PubMed Web of Science ®Google Scholar
• Santos, A. M. (2014). Body Image and Bodybuilding Culture in Three Brazilian Gyms: A Qualitative Analysis. Federal University of Bahia, Bahia, Brazil.
   Google Scholar
• Santos, A. M., da Rocha, M. S. P., & Silva, M. F. (2011). Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders. Substance Use & Misuse, 46(6), 742–748.
   PubMed Web of Science ®Google Scholar
• Schwingel, P. A., Zoppi, C. C., & Cotrim, H. P. (2011). Increased liver steatosis in anabolic-androgenic steroid users: more evidence towards toxicant-associated fatty liver disease development. Liver International, 31(8), 1240–1241.
   PubMed Web of Science ®Google Scholar
• Sheffield-Moore, M., Paddon-Jones, D., Casperson, S.L., Gilkison, C., Volpi, E., Wolf, S. E., Jiang, J., Rosenblatt, J. I., & Urban, R. J. (2006). Androgen therapy induces muscle protein anabolism in older women. The Journal of Clinical Endocrinology and Metabolism, 91(10), 3844–3849.
   PubMed Web of Science ®Google Scholar
• Stimac, D., Milić, S., Dintinjana, R. D., Kovac, D., & Ristić, S. (2002). Androgenic/Anabolic steroid-induced toxic hepatitis. Journal of Clinical Gastroenterology, 35(4), 350–352.
   PubMed Web of Science ®Google Scholar
• Strauss, R. H., Liggett, M. T., & Lanese, R. R. (1985). Anabolic steroid use and perceived effects in ten weight-trained women athletes. The Journal of the American Medical Association, 253(19), 2871–2873.
   PubMed Web of Science ®Google Scholar
• van Amsterdam, J., Opperhuizen, A., & Hartgens, F. (2010). Adverse health effects of anabolic-androgenic steroids. Regulatory Toxicology and Pharmacology, 57(1), 117–123.
   PubMed Web of Science ®Google Scholar
• Vieira, R. P., França, R. F., Damaceno-Rodrigues, N. R., Dolhnikoff, M., Caldini, E. G., Carvalho, C. R. F., & Ribeiro, W. (2008). Dose-dependent hepatic response to subchronic administration of nandrolone decanoate. Medicine and Science in Sports and Exercise, 40(5), 842–847.
   PubMed Web of Science ®Google Scholar
• Windsor, R., & Dumitru, D. (1989). Prevalence of anabolic steroid use by male and female adolescents. Medicine and Science in Sports and Exercise, 21(5), 494–497.
   PubMed Web of Science ®Google Scholar